For instance, increased expression of TAK1 and TAB1 strongly induces NF-κB activation [54], and we found that in DVT samples, the TAB1 mRNA level was decreased, which may further inhibit the TAK1-TAB complex and probably disturb the canonical NF-κB pathway. The gene discussed is NFKB1; the disease is deep vein thrombosis.